Vol. 43 No. 2 February 2012 319Schedule With Abstracts

patients and families? This workshop with ex-plore the dimensions of hope and how it af-fects the care we provide for our patients.The art and science of hope will be exploredthrough participant discussion in large andsmall group formats; an empirically-based pre-sentation on hope; a 55-word story writing exer-cise; a panel discussion of hope andhopelessness; and a presentation of evidence-based communication techniques thatstrengthen hope and the empowerment of pa-tients, families, and clinicians in the face oflife threatening and challenging palliative med-icine situations. Participants will have a chanceto practice the communication skills in dyads.

Writing for Publication: Disseminating theWisdom of Palliative Care (P9)Betty Ferrell, PhD MA FAAN FPCN CHPN�, Cityof Hope, Duarte, CA. Barbara Head, PhD RNCHPN� ACSW, University of Louisville, Louis-ville, KY. Barbara L. Jones, PhD MSW, Universityof Texas, Austin, TX. Christine Ritchie, MDMSPH, University of Alabama at Birmingham,Birmingham, AL.(All authors listed above for this session have dis-closed no relevant financial relationships.)Sponsored by HPNA

Objectives1. Identify steps in moving from ideas to a com-

plete manuscript.2. Identify steps of the publication process from

submission to acceptance.3. Discuss potential ideas for manuscripts.4. Outline a potential manuscript for

publication.This session will offer practical advice for pallia-tive care professionals to encourage publicationof their research and clinical expertise in jour-nals. The session will review topics such as theagony and the ecstasy of the publication process,getting started, first drafts, selecting a journal,responding to reviews, and other basic skills inwriting. Participants are encouraged to comewith ideas for manuscripts, and small grouptime will be devoted to assist in developing ideasand plans for publication.

It’s Not Your Mama’s End-of-LifeMedication Bag! (P10)Mary Lynn McPherson, PharmD BCPS CPE,University of Maryland, Baltimore, MD. Michael

J. LaPenta, MD FAAFP, Hospice of the Chesa-peake, Annapolis, MD.Sponsored by HPNA

Objectives1. List the most commonly requested medica-

tions for ‘‘open access’’ admission to hos-pice care, and describe the evidence basesupporting or refuting the use of thesemedications in patients with advancedillness.

2. Describe the evidence base concerning thebenefits and burdens of specific medicationclasses in patients with advanced illness in-cluding dementia, cardiovascular diseaseand diabetes.

3. Develop a strategy to detect potential drugabuse or diversion in the home hospice envi-ronment, and an action plan to handle thisclinical scenario.

4. Develop a protocol for the use of atypicalmedications such as lidocaine andketamine.

When hospice was first introduced in the U.S.and for several decades subsequent to that,drug therapy for this fragile patient populationwas fairly straightforward. An opioid, a bowelregimen, perhaps an anxiolytic or antiemeticrepresented the majority of the medication reg-imen. In recent years however, it’s a whole newball game! Many hospices now accept patientsthrough an open access program and wrestlewith the appropriateness of continuing chemo-therapeutic agents, drugs for pulmonary arte-rial hypertension, ALS and more. Practitionersmust consider when and how to discontinuemedications such as those for dementia, ALS,and comorbid conditions such as statins andantidiabetes medications. This preconferencewill address these difficult drug therapy deci-sions as well as how to handle drug abuse ordiversion in the home, a potpourri of medica-tion-related conundrums (such as the appropri-ateness of using antipsychotic agents in patientswith dementia or the cumulative risk of QT pro-longation with haloperidol and methadone),and the development of protocols for challeng-ing drugs such as ketamine and lidocaine.Hopefully you’ll go home with a few new an-swers, and a keener sense of evaluating the ap-propriateness of when to start, use, and stopmedications for hospice patients in this newday.